LLY vs AMGN
By Alex · Tickerpine
Eli Lilly and Company vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | AMGN |
|---|---|---|
| Price | $1,208.12 | $358.33 |
| Market cap | $1.08T | $193.39B |
| P/E ratio | 42.9 | 24.9 |
| ROE | 107.46% | 101.32% |
| Profit margin | 34.99% | 20.96% |
| Revenue growth | 55.50% | 5.80% |
| Dividend yield | 0.57% | 2.81% |
| Beta | 0.52 | 0.42 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs AMGN in plain English
- LLY is the bigger company — about 5.6× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 24.9 vs 42.9).
- LLY earns a higher return on equity (107% vs 101%).
- LLY is growing revenue faster (56% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.